Presentation is loading. Please wait.

Presentation is loading. Please wait.

Ipilimumab-associated Sweet syndrome in a melanoma patient

Similar presentations


Presentation on theme: "Ipilimumab-associated Sweet syndrome in a melanoma patient"— Presentation transcript:

1 Ipilimumab-associated Sweet syndrome in a melanoma patient
Rachel Gormley, MD, Karolyn Wanat, MD, Rosalie Elenitsas, MD, Julia Giles, RN, Suzanne McGettigan, MSN, CRNP, AOCN, Lynn Schuchter, MD, Junko Takeshita, MD, PhD  Journal of the American Academy of Dermatology  Volume 71, Issue 5, Pages e211-e213 (November 2014) DOI: /j.jaad Copyright © 2014 American Academy of Dermatology, Inc. Terms and Conditions

2 Fig 1 Sweet syndrome. Erythematous and edematous papules and plaques were noted over the trunk, legs, arms, and dorsal hands, some with a pseudovesicular appearance. Views of pseudovesicular lesions on the dorsal hand. Journal of the American Academy of Dermatology  , e211-e213DOI: ( /j.jaad ) Copyright © 2014 American Academy of Dermatology, Inc. Terms and Conditions

3 Fig 2 Sweet syndrome. Histopathology demonstrated spongiosis and prominent papillary dermal edema with a predominantly neutrophilic infiltrate. The inflammatory infiltrate also consisted of many eosinophils with scattered lymphocytes and histiocytes. Periodic−acid Schiff and acid-fast bacilli stains were negative for organisms (not shown). (Hematoxylin and eosin stain; original magnification: ×40.) Journal of the American Academy of Dermatology  , e211-e213DOI: ( /j.jaad ) Copyright © 2014 American Academy of Dermatology, Inc. Terms and Conditions


Download ppt "Ipilimumab-associated Sweet syndrome in a melanoma patient"

Similar presentations


Ads by Google